In April 2009, he was the recipient of a Bill and Melinda Gates Foundation grant to study exosomes as a potential TB vaccine. He received one of only 81 grants funded from over 3,000 applicants. Dr. Schorey's recent work on exosomes released from TB infected macrophages has demonstrated that these exosomes containing antigenic components of tuberculosis can be utilized for efficient antigen presentation and could provide a practical strategy in the development of a vaccine for TB.
About Dr. Wayne Comper
Dr. Comper is one of the founders, Director and Chief Science Officer of Exosome Diagnostics, Inc. Prior to Exosome Diagnostics, Dr. Comper was Chief Science Officer of AusAm Biotechnologies, Inc., a biotechnology company developing diagnostics and therapeutics to identify and treat kidney, cardiovascular and infectious diseases. Between 1991 and 2004, Dr. Comper was Reader of Biochemistry and Molecular Biology at Monash University, Clayton, Victoria, Australia. From 1974 to 1976, Dr. Comper was a postdoctoral fellow at Northwestern University Medical School in Chicago. From 1976 to 1978, he was a visiting scientist in the Department of Medical and Physiological Chemistry, Uppsala University, Sweden. In 1988, he was a Visiting Professor, Nephrology Section, Rush Medical School, Chicago, Illinois. He is the recipient of the 1992 Silver Jubilee Prize for Research at Monash University, where he also holds a Doctor of Science Degree. He has published over 170 research articles in peer-reviewed international journals. His research has attracted grants from the National Health and Medical Research Council of Australia, the Diabetes Foundation of Australia, The Australian Kidney Foundation and the Juvenile Diabetes Foundation International.
Dr. Comper and his team at Exosome Diagnostics are studying biomarkers, including genetic signatures creat
|SOURCE Aethlon Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved